Tolerance Induction at the Early Maternal-Placental Interface Through Selective Cell Recruitment and Targeting by Immune Polypeptides
Pregnancy challenges immune cells and immunomodulatory circuits of the mother and the developing fetus to dynamically adapt to each other in an homeostatic and tolerant environment for fetal growth. This entails the coordination of multiple cellular processes all devoted to accommodate and nourish t...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
2013
|
| Materias: | |
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 30108caa a22021017a 4500 | ||
|---|---|---|---|
| 001 | PAPER-24311 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230607131918.0 | ||
| 008 | 190411s2013 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-84875051131 | |
| 024 | 7 | |2 cas |a chemokine receptor CCR1, 265970-50-1; inducible nitric oxide synthase, 501433-35-8; interleukin 12, 138415-13-1; vasoactive intestinal polypeptide, 37221-79-7; CCL5 protein, human; Chemokine CCL5; Chemokines; Vasoactive Intestinal Peptide, 37221-79-7 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a AAJID | ||
| 100 | 1 | |a Pérez Leirós, C. | |
| 245 | 1 | 0 | |a Tolerance Induction at the Early Maternal-Placental Interface Through Selective Cell Recruitment and Targeting by Immune Polypeptides |
| 260 | |c 2013 | ||
| 270 | 1 | 0 | |m Ramhorst, R.; Immunopharmacology Laboratory, School of Sciences, University of Buenos Aires, IQUIBICEN-CONICET, Int. Guiraldes 2160, Pabellon 2 Piso 4, Ciudad Univ., C1428EHA, Buenos Aires, Argentina; email: rramhorst@qb.fcen.uba.ar |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Mor, G., Cardenas, I., The immune system in pregnancy: a unique complexity (2010) Am J Reprod Immunol, 63, pp. 425-433 | ||
| 504 | |a Redman, C.W.G., Sargent, I.L., Immunology of pre-eclampsia (2010) Am J Reprod Immunol, 63, pp. 534-543 | ||
| 504 | |a Dekel, N., Gnainsky, Y., Granot, I., Mor, G., Inflammation and implantation (2010) Am J Reprod Immunol, 63, pp. 17-21 | ||
| 504 | |a Moser, G., Gauster, M., Orendi, K., Glasner, A., Theuerkauf, R., Huppertz, B., Endoglandular trophoblast, an alternative route of trophoblast invasion? Analysis with novel confrontation co-culture models (2010) Hum Reprod, 25, pp. 1127-1136 | ||
| 504 | |a Fitzgerald, J.S., Germeyer, A., Huppertz, B., Jeschke, U., Knöfler, M., Moser, G., Scholz, C., Markert, U.R., Governing the invasive trophoblast: current aspects on intra- and extracellular regulation (2010) Am J Reprod Immunol, 63, pp. 492-505 | ||
| 504 | |a Burton, G.J., Jauniaux, E., Charnock-Jones, D.S., Human early placental development: potential roles of the endometrial glands (2007) Placenta, 28 (SUPPL. A), pp. S64-S69 | ||
| 504 | |a Daher, S., de Arruda Geraldes Denardi, K., Blotta, M.H., Mamoni, R.L., Reck, A.P., Camano, L., Mattar, R., Cytokines in recurrent pregnancy loss (2004) J Reprod Immunol, 62, pp. 151-157 | ||
| 504 | |a Clark, D.A., Yu, G., Arck, P.C., Levy, G.A., Gorczynski, R.M., MD-1 is a critical part of the mechanism causing Th1-cytokine-triggered murine fetal loss syndrome (2003) Am J Reprod Immunol, 49, pp. 297-307 | ||
| 504 | |a Kwak-Kim, J., Yang, K.M., Gilman-Sachs, A., Recurrent pregnancy loss: a disease of inflammation and coagulation (2009) J Obstet Gynaecol Res, 35, pp. 609-622 | ||
| 504 | |a Girardi, G., Yarilin, D., Thurman, J.M., Holers, V.M., Salmon, J.E., Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction (2006) J Exp Med, 203, pp. 2165-2175 | ||
| 504 | |a Gomez-Lopez, N., Guilbert, L.J., Olson, D.M., Invasion of the leukocytes into the fetal-maternal interface during pregnancy (2010) J Leukoc Biol, 88, pp. 625-633 | ||
| 504 | |a Ashkar, A.A., Di Santo, J.P., Croy, B.A., Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy (2000) J Exp Med, 192, pp. 259-270 | ||
| 504 | |a van den Heuvel, M.J., Xie, X., Tayade, C., Peralta, C., Fang, Y., Leonard, S., Paffaro Jr., V.A., Croy, B.A., A review of trafficking and activation of uterine natural killer cells (2005) Am J Reprod Immunol, 54, pp. 322-331 | ||
| 504 | |a Harris, L.K., IFPA Gabor Than Award lecture: transformation of the spiral arteries in human pregnancy: key events in the remodelling timeline (2011) Placenta, 32 (SUPPL. 2), pp. S154-S158 | ||
| 504 | |a Moffett-King, A., Natural killer cells and pregnancy (2002) Nat Rev Immunol, 2, pp. 656-663 | ||
| 504 | |a Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Mandelboim, O., Decidual NK cells regulate key developmental processes at the human fetal-maternal interface (2006) Nat Med, 12, pp. 1065-1074 | ||
| 504 | |a Mosser, D.M., Edwards, J.P., Exploring the full spectrum of macrophage activation (2008) Nat Rev Immunol, 8, pp. 958-969 | ||
| 504 | |a Strazewski Chavez, S.L., Abrahams, V.M., Mor, G., The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy (2005) Endocr Rev, 26, pp. 877-897 | ||
| 504 | |a Fest, S., Aldo, P.B., Abrahams, V.M., Visintin, I., Alvero, A., Chen, R., Chavez, S.L., Mor, G., Trophoblast-macrophage interactions: a regulatory network for the protection of pregnancy (2007) Am J Reprod Immunol, 57, pp. 55-66 | ||
| 504 | |a Abrahams, V.M., Kim, Y.M., Straszewski, S.L., Romero, R., Mor, G., Macrophages and apoptotic cell clearance during pregnancy (2004) Am J Reprod Immunol, 51, pp. 275-282 | ||
| 504 | |a Nagamatsu, T., Schust, D.J., The contribution of macrophages to normal and pathological pregnancies (2010) Am J Reprod Immunol, 63, pp. 460-471 | ||
| 504 | |a Aluvihare, V.R., Kallikourdis, M., Betz, A.G., Regulatory T cells mediate maternal tolerance to the fetus (2004) Nat Immunol, 5, pp. 266-271 | ||
| 504 | |a Terness, P., Kallikourdis, M., Betz, A.G., Rabinovich, G.A., Saito, S., Clark, D.A., Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells (2007) Am J Reprod Immunol, 58, pp. 238-254 | ||
| 504 | |a Leber, A., Teles, A., Zenclussen, A.C., Regulatory T cells and their role in pregnancy (2010) Am J Reprod Immunol, 63, pp. 445-459 | ||
| 504 | |a Zenclussen, A.C., Gerlof, K., Zenclussen, M.L., Sollwedel, A., Bertoja, A.Z., Ritter, T., Kotsch, K., Volk, H.D., Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model (2005) Am J Pathol, 166, pp. 811-822 | ||
| 504 | |a Ramhorst, R., Fraccaroli, L., Aldo, P., Alvero, A.B., Cardenas, I., Perez Leirós, C., Mor, G., Modulation and recruitment of inducible regulatory T cells by first trimester trophoblast cells (2012) Am J Reprod Immunol, 67, pp. 17-27 | ||
| 504 | |a Saito, S., Nakashima, A., Shima, T., Ito, M., Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy (2010) Am J Reprod Immunol, 63, pp. 601-610 | ||
| 504 | |a Schumacher, A., Wafula, P.O., Teles, A., El-Mousleh, T., Linzke, N., Zenclussen, M.L., Langwisch, S., Zenclussen, A.C., Blockage of heme oxygenase-1 abrogates the protective effect of regulatory T cells on murine pregnancy and promotes the maturation of dendritic cells (2012) PLoS ONE, 7, pp. e42301 | ||
| 504 | |a Munoz-Suano, A., Hamilton, A.B., Betz, A.G., Gimme shelter: the immune system during pregnancy (2011) Immunol Rev, 241, pp. 20-38 | ||
| 504 | |a Warning, J.C., McCracken, S.A., Morris, J.M., A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system (2011) Reproduction, 141, pp. 715-724 | ||
| 504 | |a Rossi, D., Zlotnik, A., The biology of chemokines and their receptors (2000) Annu Rev Immunol, 18, pp. 217-242 | ||
| 504 | |a Bromley, S.K., Mempel, T.R., Luster, A.D., Orchestrating the orchestrators: chemokines in control of T cell traffic (2008) Nat Immunol, 9, pp. 970-980 | ||
| 504 | |a Fraccaroli, L., Alfieri, J., Pérez Leiros, C., Ramhorst, R., Immunomodulatory effects of chemokines during the early implantation window (2009) Front Biosc, 1, pp. 288-298 | ||
| 504 | |a Lutther, A.J., Cyster, A.C., Chemokines as regulators of T cell differentiation (2001) Nat Med, 2, pp. 102-107 | ||
| 504 | |a Moser, B., Loetscher, P., Lymphocyte traffic control by chemokines (2001) Nat Med, 2, pp. 123-128 | ||
| 504 | |a Sohy, D., Yano, H., de Nadai, P., Urizar, E., Guillabert, A., Javitch, J.A., Parmentier, M., Springael, J.Y., Hetero-oligomerization of CCR2,CCR5, and CXCR4 and the protean effects of "selective" antagonists (2009) J Biol Chem, 284, pp. 31270-31279 | ||
| 504 | |a Raman, D., Sobolik-Delmaire, T., Richmond, A., Chemokines in health and disease (2011) Exp Cell Res, 317, pp. 575-589 | ||
| 504 | |a Neel, N.F., Barzik, M., Raman, D., Sobolik-Delmaire, T., Sai, J., Ham, A.J., Mernaugh, R.L., Richmond, A., VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis (2009) J Cell Sci, 122, pp. 1882-1894 | ||
| 504 | |a Raman, D., Neel, N.F., Sai, J., Mernaugh, R.L., Ham, A.J., Richmond, A.J., Characterization of chemokine receptor CXCR2 interacting proteins using a proteomics approach to define the CXCR2 "chemosynapse" (2009) Methods Enzymol, 460, pp. 315-330 | ||
| 504 | |a Raman, D., Sai, J., Neel, N.F., Chew, C.S., Richmond, A., LIM and SH3 protein-1 modulates CXCR2- mediated cell migration (2010) PLoS ONE, 5, pp. e10050 | ||
| 504 | |a Kallikourdis, M., Andersen, K.G., Welch, K.A., Betz, A.G., Alloantigen-enhanced accumulation of CCR5+ effector regulatory T cells in the gravid uterus (2007) PNAS, 104, pp. 594-599 | ||
| 504 | |a Mold, J.E., Michaëlsson, J., Burt, T.D., Muench, M.O., Beckerman, P.K., Busch, M.P., Lee, T., McCune, J.M., Maternal alloantigens promote the development of tolerogenic fetal regulatory t cells in utero (2008) Science, 322, pp. 1562-1565 | ||
| 504 | |a Mjösberg, J., Svensson, J., Johansson, E., Hellström, L., Casas, R., Jenmalm, M.C., Boij, R., Ernerudh, J., Systemic reduction of functionally suppressive CD4dimCD25highFoxp3+ Tregs in human second trimester pregnancy is induced by progesterone and 17beta-estradiol (2009) J Immunol, 183, pp. 759-769 | ||
| 504 | |a Mjösberg, J., Berg, G., Jenmalm, M.C., Ernerudh, J., FOXP3+ regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua (2010) Biol Reprod, 82, pp. 698-705 | ||
| 504 | |a Tilburgs, T., Roelen, D.L., van der Mast, B.J., de Groot-Swings, G.M., Kleijburg, C., Scherjon, S.A., Claas, F.H., Evidence for a selective migration of fetus-specific CD4+CD25bright regulatory T cells from the peripheral blood to the decidua in human pregnancy (2008) J Immunol, 180, pp. 5737-5745 | ||
| 504 | |a Tilburgs, T., Schonkeren, D., Eikmans, M., Nagtzaam, N.M., Datema, G., Swings, G.M., Prins, F., Claas, F.H., Human decidual tissue contains differentiated CD8+ effector-memory T cells with unique properties (2010) J Immunol, 185, pp. 4470-4477 | ||
| 504 | |a Graham, C.H., Hawley, T.S., Hawley, R.G., MacDougall, J.R., Kerbel, R.S., Khoo, N., Lala, P.K., Establishment and characterization of first trimester human trophoblast cells with extended lifespan (1993) Exp Cell Res, 206, pp. 204-211 | ||
| 504 | |a Straszewski-Chavez, S.L., Abrahams, V.M., Alvero, A.B., Aldo, P.B., Ma, Y., Guller, S., Romero, R., Mor, G., The isolation and characterization of a novel telomerase immortalized first trimester trophoblast cell line, Swan 71 (2009) Placenta, 30, pp. 939-948 | ||
| 504 | |a Nancy, P., Tagliani, E., Tay, C.S., Asp, P., Levy, D.E., Erlebacher, A., Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface (2012) Science, 336, pp. 1317-1321 | ||
| 504 | |a Cocchi, F., DeVico, A.L., Garzino-Demo, A., Arya, S.K., Gallo, R.C., Lusso, P., Identification of RANTES, MIP-1αand MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells (1995) Science, 270, pp. 1811-1815 | ||
| 504 | |a Hornung, D., Klingel, K., Dohrn, K., Kandolf, R., Wallwiener, D., Tayler, R.N., Regulated on activation, normal T-cell expressed and -secreted mRNA expression in normal endometrium and endometriotic implants: assessment of autocrine/paracrine regulation by in situ hybridization (2001) Am J Pathol, 158, pp. 1949-1954 | ||
| 504 | |a Faunce, D., Stein-Streilein, J., NKT Cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance (2002) J Immunol, 169, pp. 31-38 | ||
| 504 | |a Nakamura, T., Sonoda, K., Faunce, D., Gumperz, J., Yamamura, T., Miyake, S., Stein-Streilein, T., CD4+ NKT cells, but not conventional CD4+ T cells are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged site (2003) J Immunol, 171, pp. 1266-1271 | ||
| 504 | |a Rabinovich, G.A., Ramhorst, R.E., Rubinstein, N., Corigliano, A., Daroqui, M.C., Kier-Joffé, E.B., Fainboim, L., Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms (2002) Cell Death Differ, 9, pp. 661-670 | ||
| 504 | |a Ramhorst, R., Patel, R., Corigliano, A., Etchepareborda, J.J., Fainboim, L., Schust, D., Induction of maternal tolerance to fetal alloantigens by RANTES production (2006) Am J Reprod Immunol, 56, pp. 302-311 | ||
| 504 | |a Paria, B., Reese, J., Das, S., Dey, S., Deciphering the cross talk of implantation: advances and challenges (2002) Science, 296, pp. 2185-2188 | ||
| 504 | |a Fraccaroli, L., Alfieri, J., Larocca, L., Calafat, M., Mor, G., Pérez Leiros, C., Ramhorst, R., A potential tolerogenic immune mechanism in a trophoblast cell line through the activation of chemokine-induced T cell death and regulatory T cell modulation (2009) Hum Reprod, 24, pp. 166-175 | ||
| 504 | |a Ramhorst, R., Gutiérrez, G., Corigliano, A., Junovich, G., Fainboim, L., Implication of RANTES in the modulation of alloimmune response by progesterone during pregnancy (2007) Am J Reprod Immunol, 57, pp. 147-152 | ||
| 504 | |a Kim, M.J., Romero, R., Kim, C.J., Tarca, A.L., Chhauy, S., LaJeunesse, C., Lee, D.C., Kim, J.S., Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease (2009) J Immunol, 182, pp. 3919-3927 | ||
| 504 | |a Fraccaroli, L., Grasso, E., Hauk, V., Cortelezzi, M., Calo, G., Pérez Leirós, C., Ramhorst, R., Defects in the vasoactive intestinal peptide (VIP)/VPAC system during early stages of the placental-maternal leucocyte interaction impair the maternal tolerogenic response (2012) Clin Exp Immunol, 170, pp. 310-320 | ||
| 504 | |a Said, S.I., The discovery of VIP: initially looked for in the lung, isolated from intestine, and identified as a neuropeptide (2007) Peptides, 28, pp. 1620-1621 | ||
| 504 | |a Couvineau, A., Laburthe, M., VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins (2012) Br J Pharmacol, 166, pp. 42-50 | ||
| 504 | |a Onoue, S., Misaka, S., Yamada, S., Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applications (2008) Naunyn-Schmiedeberg's Arch Pharmacol, 377, pp. 579-590 | ||
| 504 | |a Harmar, A.J., Fahrenkrug, J., Gozes, I., Laburthe, M., May, V., Pisegna, J.R., Vaudry, D., Said, S.I., Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1 (2012) Br J Pharmacol, 166, pp. 4-17 | ||
| 504 | |a Delgado, M., Munoz-Elias, E.J., Gomariz, R.P., Ganea, D., Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation (1999) J Immunol, 162, pp. 4685-4696 | ||
| 504 | |a Gressens, P., Marret, S., Hill, J.M., Brenneman, D.E., Gozes, I., Fridkin, M., Evrard, P., Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain (1997) J Clin Invest, 100, pp. 390-397 | ||
| 504 | |a Månsson, B., Nilsson, B.O., Ekström, J., Effects of repeated infusions of substance P and vasoactive intestinal peptide on the weights of salivary glands subjected to atrophying influences in rats (1990) Br J Pharmacol, 101, pp. 853-858 | ||
| 504 | |a Ekström, J., Mansson, B., Tobin, G., Vasoactive intestinal peptide evokes secretion of fluid and protein from rat salivary glands and the development of supersensitivity (1983) Acta Physiol Scand, 119, pp. 169-175 | ||
| 504 | |a Jovanovic, S., Grbovic, L., Jovanovic, A., Pregnancy does not alter the response of uterine arteries to vasoactive intestinal polypeptide (2000) Mol Hum Reprod, 6, pp. 361-368 | ||
| 504 | |a Roca, V., Larocca, L., Calafat, M., Aisemberg, J., Meiss, R., Franchi, A., Perez Leiros, C., Reduced nitric oxide synthase and cyclo-oxygenase activity in the uterus of non-obese diabetic mice (2006) Reproduction, 32, pp. 931-938 | ||
| 504 | |a Lara-Marquez, M., O'Dorisio, M., O'Dorisio, T., Shah, M., Karacay, B., Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells (2006) J Immunol, 166, pp. 2522-2530 | ||
| 504 | |a Martinez, C., Delgado, M., Abad, C., Gomariz, R.P., Ganea, D., Leceta, J., Regulation of VIP production and secretion by murine lymphocytes (1999) J Neuroimmunol, 93, pp. 126-138 | ||
| 504 | |a Li, J.M., Southerland, L., Hossain, M.S., Giver, C.R., Wang, Y., Darlak, K., Harris, W., Waller, E.K., Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice (2011) J Immunol, 187, pp. 1057-1065 | ||
| 504 | |a Lodde, B.M., Mineshiba, F., Wang, J., Cotrim, P., Afione, S., Tak, P.P., Baum, B.J., Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome (2006) Ann Rheum Dis, 65, pp. 195-200 | ||
| 504 | |a Delgado, M., Abad, C., Martinez, C., Leceta, J., Gomariz, R.P., Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease (2001) Nat Med, 7, pp. 563-568 | ||
| 504 | |a Gonzalez-Rey, E., Delgado, M., Vasoactive intestinal peptide and regulatory T-cell induction: a new mechanism and therapeutic potential for immune homeostasis (2007) Trends Mol Med, 13, pp. 241-251 | ||
| 504 | |a Yadav, M., Goetzl, E.J., Vasoactive intestinal peptide-mediated Th17 differentiation: an expanding spectrum of vasoactive intestinal peptide effects in immunity and autoimmunity (2008) Ann N Y Acad Sci, 1144, pp. 83-89 | ||
| 504 | |a Jimeno, R., Gomariz, R.P., Gutiérrez-Cañas, I., Martínez, C., Juarranz, Y., Leceta, J., New insights into the role of VIP on the ratio of T-cell subsets during the development of autoimmune diabetes (2010) Immunol Cell Biol, 88, pp. 734-745 | ||
| 504 | |a Rosignoli, F., Torroba, M., Juarranz, Y., Gomez, I.A., Martinez, C., Gomariz, R.P., Pérez Leirós, C., Leceta, J., VIP and tolerance induction in autoimmunity (2006) Ann N Y Acad Sci, 6, pp. 1-6 | ||
| 504 | |a Chorny, A., Gonzalez-Rey, E., Fernandez Martin, A., Ganea, D., Delgado, M., Vasointestinal peptide induces regulatory dendritic cells that prevent acute graft-host disease while maintaining the graft-versus tumor response (2006) Blood, 107, pp. 3787-3794 | ||
| 504 | |a Toscano, M.G., Delgado, M., Kong, W., Martin, F., Skarica, M., Ganea, D., Dendritic cells transduced with lentiviral vectors expressing VIP differentiate into VIP-secreting tolerogenic-like DCs (2010) Mol Ther, 18, pp. 1035-1045 | ||
| 504 | |a Juarranz, M.G., Santiago, B., Torroba, M., Gutierrez-Cañas, I., Palao, G., Galindo, M., Abad, C., Gomariz, R.P., Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells (2004) Rheumatology, 43, pp. 416-422 | ||
| 504 | |a Carrión, M., Juarranz, Y., Pérez-García, S., Jimeno, R., Pablos, J.L., Gomariz, R.P., Gutiérrez-Cañas, I., RNA sensors in human osteoarthritis and rheumatoid arthritis synovial fibroblasts: immune regulation by vasoactive intestinal peptide (2011) Arthritis Rheum, 63, pp. 1626-1636 | ||
| 504 | |a Jimeno, R., Leceta, J., Martínez, C., Gutiérrez-Cañas, I., Pérez-García, S., Carrión, M., Gomariz, R.P., Juarranz, Y., Effect of VIP on the balance between cytokines and master regulators of activated helper T cells (2012) Immunol Cell Biol, 90, pp. 178-186 | ||
| 504 | |a Pozo, D., Anderson, P., Gonzalez-Rey, E., Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide (2009) J Immunol, 183, pp. 4346-4359 | ||
| 504 | |a Yadav, M., Rosenbaum, J., Goetzl, E.J., Cutting edge: vasoactive intestinal peptide (VIP) induces differentiation of Th17 cells with a distinctive cytokine profile (2008) J Immunol, 180, pp. 2772-2776 | ||
| 504 | |a Said, S.I., Hamidi, S.A., Gonzalez Bosc, L., Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis? (2010) Eur Respir J, 35, pp. 730-734 | ||
| 504 | |a Leceta, J., Martínez, C., Delgado, M., Garrido, E., Gomariz, R.P., Expression of vasoactive intestinal peptide in lymphocytes: a possible endogenous role in the regulation of the immune system (1996) Adv Neuroimmunol, 6, pp. 29-36 | ||
| 504 | |a Voice, J.K., Grinninger, C., Kong, Y., Bangale, Y., Paul, S., Goetzl, E.J., Roles of vasoactive intestinal peptide (VIP) in the expression of different immune phenotypes by wild-type mice and T cell-targeted type II VIP receptor transgenic mice (2003) J Immunol, 170, pp. 308-314 | ||
| 504 | |a Hill, J.M., McCune, S.K., Alvero, R.J., Glazner, G.W., Henins, K.A., Stanziale, S.F., Keimowitz, J.R., Brenneman, D.E., Maternal vasoactive intestinal peptide and the regulation of embryonic growth in the rodent (1996) J Clin Invest, 97, pp. 202-208 | ||
| 504 | |a Spong, C.Y., Lee, S.J., McCune, S.K., Gibney, G., Abebe, D.T., Brenneman, D.E., Hill, J.M., Regulation of postimplantation mouse embryonic growth by maternal vasoactive intestinal peptide (1999) Ann N Y Acad Sci, 897, pp. 101-108 | ||
| 504 | |a Spong, C., Lee, S., Mcune, S., Gibney, G., Abebe, D., Alvero, R., Brenneman, E., Hill, G., Maternal regulation of embryonic growth: the role of vasoactive intestinal peptide (1999) Endocrinology, 140, pp. 917-924 | ||
| 504 | |a Hill, J.M., Hauser, J.M., Sheppard, L.M., Abebe, D., Spivak-Pohis, I., Kushnir, M., Deitch, I., Gozes, I., Blockage of VIP during mouse embryogenesis modifies adult behavior and results in permanent changes in brain chemistry (2007) J Mol Neurosci, 31, pp. 183-200 | ||
| 504 | |a Gressens, P., Paindaveine, B., Hill, J.M., Evrard, P., Brenneman, D.E., Vasoactive intestinal peptide shortens both G1 and S phases of neural cell cycle in whole postimplantation cultured mouse embryos (1994) Eur J Neurosci, 10, pp. 1734-1742 | ||
| 504 | |a Tyrrell, S., Landis, S.C., The appearance of NPY and VIP in sympathetic neuroblasts and subsequent alterations in their expression (1994) J Neurosci, 14, pp. 4529-4547 | ||
| 504 | |a Lim, M.A., Stack, C.M., Cuasay, K., Stone, M.M., McFarlane, H.G., Waschek, J.A., Hill, J.M., Regardless of genotype, offspring of VIP-deficient female mice exhibit developmental delays and deficits in social behavior (2008) Int J Dev Neurosci, 26, pp. 423-434 | ||
| 504 | |a Graf, A.H., Hütter, W., Hacker, G.W., Steiner, H., Anderson, V., Staudach, A., Dietze, O., Localization and distribution of vasoactive neuropeptides in the human placenta (1996) Placenta, 17, pp. 413-421 | ||
| 504 | |a Marzioni, D., Fiore, G., Giordano, A., Nabissi, M., Florio, P., Verdenelli, F., Petraglia, F., Castellucci, M., Placental expression of substance P and vasoactive intestinal peptide: evidence for a local effect on hormone release (2005) J Clin Endocrinol Metab, 90, pp. 2378-2383 | ||
| 504 | |a Deutsch, P.J., Sun, Y., Kroog, G.S., Vasoactive intestinal peptide increases intracellular cAMP and gonadotropin-alpha gene activity in JEG-3 syncytial trophoblasts. Constraints posed by desensitization (1990) J Biol Chem, 265, pp. 10274-10281 | ||
| 504 | |a Ottesen, B., Ulrichsen, H., Fahrenkrug, J., Larsen, J.J., Wagner, G., Schierup, L., Søndergaard, F., Vasoactive intestinal polypeptide and the female genital tract: relationship to reproductive phase and delivery (1982) Am J Obstet Gynecol, 143, pp. 414-420 | ||
| 504 | |a Roca, V., Calafat, M., Larocca, L., Ramhorst, R., Farina, M., Franchi, A.M., Pérez Leiros, C., Potential immunomodulatory role of VIP in the implantation sites of prediabetic nonobese diabetic mice (2009) Reproduction, 138, pp. 733-742 | ||
| 504 | |a Larocca, L., Hauk, V., Calafat, M., Roca, V., Fraccaroli, L., Franchi, A., Ramhorst, R., Pérez Leiros, C., Modulation of macrophage inflammatory profile in pregnant nonobese diabetic (NOD) mice (2011) Mol Cell Endocrinol, 333, pp. 112-118 | ||
| 504 | |a Fraccaroli, L., Alfieri, J., Larocca, L., Calafat, M., Roca, V., Lombardi, E., Ramhorst, R., Pérez Leirós, C., VIP modulates the pro-inflammatory maternal response, inducing tolerance to trophoblast cells (2009) Br J Pharmacol, 156, pp. 116-126 | ||
| 504 | |a Fraccaroli, L., Grasso, E., Zeitler, E., Lombardi, E., Gogorza, S., Etchepareborda, J.J., Nagle, C., Ramhorst, R., Modulation of maternal LIF producers T cells by trophoblast and paternal antigens (2011) Am J Reprod Immunol, 65, pp. 133-145 | ||
| 504 | |a Ilarregui, J.M., Croci, D.O., Bianco, G.A., Toscano, M.A., Salatino, M., Vermeulen, M.E., Geffner, J.R., Rabinovich, G.A., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 (2009) Nat Immunol, 10, pp. 981-991 | ||
| 504 | |a Ramhorst, R.E., Giribaldi, L., Fraccaroli, L., Toscano, M.A., Stupirski, J.C., Romero, M.D., Durand, E.S., Rabinovich, G.A., Galectin-1 confers immune privilege to human trophoblast: implications in recurrent fetal loss (2012) Glycobiology, 22, pp. 1374-1386 | ||
| 504 | |a Blois, S.M., Ilarregui, J.M., Tometten, M., Garcia, M., Orsal, A.S., Cordo-Russo, R., Toscano, M.A., Arck, P.C., A pivotal role for galectin-1 in fetomaternal tolerance (2007) Nat Med, 13, pp. 1450-1457 | ||
| 504 | |a Rabinovich, G.A., Croci, D.O., Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer (2012) Immunity, 36, pp. 322-335 | ||
| 504 | |a Than, N.G., Romero, R., Kim, C.J., McGowen, M.R., Papp, Z., Wildman, D.E., Galectins: guardians of eutherian pregnancy at the maternal-fetal interface (2012) Trends Endocrinol Metab, 23, pp. 23-31 | ||
| 504 | |a Than, N.G., Erez, O., Wildman, D.E., Tarca, A.L., Edwin, S.S., Abbas, A., Hotra, J., Romero, R., Severe preeclampsia is characterized by increased placental expression of galectin-1 (2008) J Matern Fetal Neonatal Med, 21, pp. 429-442 | ||
| 520 | 3 | |a Pregnancy challenges immune cells and immunomodulatory circuits of the mother and the developing fetus to dynamically adapt to each other in an homeostatic and tolerant environment for fetal growth. This entails the coordination of multiple cellular processes all devoted to accommodate and nourish the fetus while protecting the mother from endogenous and exogenous threatens. From the earliest stages of pregnancy, several strategies to efficiently communicate immune and trophoblast cells within the interface or at a distance were identified and chemokines might act at on different targets through direct or indirect mechanisms. Here, we briefly review some mechanisms of T regulatory cell recruitment to the early maternal-placental interfaces to accomplish immunotolerance and homeostatic control and we discuss evidence on two locally released polypeptides, RANTES (regulated on activation, normal, T-cell expressed, and secreted) and vasoactive intestinal peptide (VIP), as novel contributors to the multiplicity of immune tolerant responses and uterine quiescence requirements. © 2013 John Wiley & Sons A/S. |l eng | |
| 593 | |a Immunopharmacology Laboratory, School of Sciences, University of Buenos Aires, IQUIBICEN-CONICET, Buenos Aires, Argentina | ||
| 690 | 1 | 0 | |a CHEMOKINES |
| 690 | 1 | 0 | |a MATERNAL TOLERANCE |
| 690 | 1 | 0 | |a PREGNANCY |
| 690 | 1 | 0 | |a RANTES |
| 690 | 1 | 0 | |a VASOACTIVE INTESTINAL PEPTIDE |
| 690 | 1 | 0 | |a CHEMOKINE RECEPTOR CCR1 |
| 690 | 1 | 0 | |a CHEMOKINE RECEPTOR CCR3 |
| 690 | 1 | 0 | |a CHEMOKINE RECEPTOR CCR5 |
| 690 | 1 | 0 | |a CHEMOKINE RECEPTOR CXCR |
| 690 | 1 | 0 | |a INDUCIBLE NITRIC OXIDE SYNTHASE |
| 690 | 1 | 0 | |a INTERLEUKIN 10 |
| 690 | 1 | 0 | |a INTERLEUKIN 12 |
| 690 | 1 | 0 | |a RANTES |
| 690 | 1 | 0 | |a TUMOR NECROSIS FACTOR ALPHA |
| 690 | 1 | 0 | |a VASOACTIVE INTESTINAL POLYPEPTIDE |
| 690 | 1 | 0 | |a CYTOKINE RELEASE |
| 690 | 1 | 0 | |a IMMUNE RESPONSE |
| 690 | 1 | 0 | |a IMMUNOLOGICAL TOLERANCE |
| 690 | 1 | 0 | |a MATERNAL PLACENTAL INTERFACE |
| 690 | 1 | 0 | |a MOLECULAR INTERACTION |
| 690 | 1 | 0 | |a MOTHER FETUS RELATIONSHIP |
| 690 | 1 | 0 | |a PRIORITY JOURNAL |
| 690 | 1 | 0 | |a REGULATORY T LYMPHOCYTE |
| 690 | 1 | 0 | |a REVIEW |
| 690 | 1 | 0 | |a TH1 CELL |
| 690 | 1 | 0 | |a TH17 CELL |
| 690 | 1 | 0 | |a CHEMOKINE CCL5 |
| 690 | 1 | 0 | |a CHEMOKINES |
| 690 | 1 | 0 | |a FEMALE |
| 690 | 1 | 0 | |a FETUS |
| 690 | 1 | 0 | |a HUMANS |
| 690 | 1 | 0 | |a IMMUNE TOLERANCE |
| 690 | 1 | 0 | |a LYMPHOCYTE ACTIVATION |
| 690 | 1 | 0 | |a PREGNANCY |
| 690 | 1 | 0 | |a T-LYMPHOCYTES, REGULATORY |
| 690 | 1 | 0 | |a TROPHOBLASTS |
| 690 | 1 | 0 | |a VASOACTIVE INTESTINAL PEPTIDE |
| 650 | 1 | 7 | |2 spines |a HOMEOSTASIS |
| 650 | 1 | 7 | |2 spines |a PLACENTA |
| 700 | 1 | |a Ramhorst, R. | |
| 773 | 0 | |d 2013 |g v. 69 |h pp. 359-368 |k n. 4 |p Am. J. Reprod. Immunol. |x 10467408 |w (AR-BaUEN)CENRE-3647 |t American Journal of Reproductive Immunology | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-84875051131&doi=10.1111%2faji.12087&partnerID=40&md5=601f977cd62375c7feb3a5dfbe8ada0e |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1111/aji.12087 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_10467408_v69_n4_p359_PerezLeiros |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_10467408_v69_n4_p359_PerezLeiros |y Registro en la Biblioteca Digital |
| 961 | |a paper_10467408_v69_n4_p359_PerezLeiros |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 85264 | ||